Functional Ischemia and Muscle Damage in Duchenne Muscular Dystrophy
Author Information
Author(s): Asai Akihiro, Sahani Nita, Kaneki Masao, Ouchi Yasuyoshi, Martyn J.A. Jeevendra, Yasuhara Shingo Egusa
Primary Institution: Department of Anesthesiology and Critical Care, Shriners Hospital for Children, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America
Hypothesis
Is functional ischemia necessary and sufficient to cause contraction-induced myofiber damage in Duchenne muscular dystrophy?
Conclusion
Functional ischemia plays a primary role in contraction-induced myofiber damage in mdx mice, and treatment with tadalafil can reduce this damage.
Supporting Evidence
- Functional ischemia is necessary for contraction-induced myofiber damage in mdx mice.
- Tadalafil treatment significantly reduced muscle damage in mdx mice.
- Control mice showed normal blood flow response to muscle contraction, unlike mdx mice.
- Pharmacological interventions improved blood flow and reduced muscle damage.
- Evidence supports the existence of a 'two-hit' mechanism in the pathogenesis of muscular dystrophy.
- NO and H2O2 production was significantly impaired in mdx mice during muscle contraction.
- Functional ischemia alone was insufficient to cause the same level of damage seen in mdx mice.
Takeaway
Duchenne muscular dystrophy causes muscle damage due to poor blood flow, and a drug called tadalafil can help protect the muscles.
Methodology
In vivo microscopy was used to measure blood flow and myofiber damage in mdx mice, comparing responses to pharmacological treatments.
Potential Biases
Potential bias in interpreting results due to the use of a single animal model.
Limitations
The study primarily used mdx mice, which may not fully represent human conditions of Duchenne muscular dystrophy.
Participant Demographics
Mice used were mdx mice, a model for Duchenne muscular dystrophy.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website